ArticleNature reviews. Neurology2015
Neuromuscular disease: CRISPR/Cas9 gene-editing platform corrects mutations associated with Duchenne muscular dystrophy.
Heather WoodPubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it